vs

Side-by-side financial comparison of Charles River Laboratories (CRL) and Qnity Electronics, Inc. (Q). Click either name above to swap in a different company.

Qnity Electronics, Inc. is the larger business by last-quarter revenue ($1.3B vs $994.2M, roughly 1.3× Charles River Laboratories). Qnity Electronics, Inc. runs the higher net margin — 16.5% vs -27.8%, a 44.4% gap on every dollar of revenue. On growth, Qnity Electronics, Inc. posted the faster year-over-year revenue change (11.1% vs -0.8%). Qnity Electronics, Inc. produced more free cash flow last quarter ($568.0M vs $58.6M).

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.

CRL vs Q — Head-to-Head

Bigger by revenue
Q
Q
1.3× larger
Q
$1.3B
$994.2M
CRL
Growing faster (revenue YoY)
Q
Q
+12.0% gap
Q
11.1%
-0.8%
CRL
Higher net margin
Q
Q
44.4% more per $
Q
16.5%
-27.8%
CRL
More free cash flow
Q
Q
$509.4M more FCF
Q
$568.0M
$58.6M
CRL

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CRL
CRL
Q
Q
Revenue
$994.2M
$1.3B
Net Profit
$-276.6M
$211.0M
Gross Margin
45.1%
Operating Margin
-28.5%
21.3%
Net Margin
-27.8%
16.5%
Revenue YoY
-0.8%
11.1%
Net Profit YoY
-28.9%
6.0%
EPS (diluted)
$-5.57
$1.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRL
CRL
Q
Q
Q4 25
$994.2M
Q3 25
$1.0B
$1.3B
Q2 25
$1.0B
Q1 25
$984.2M
Q4 24
$1.0B
Q3 24
$1.0B
$1.1B
Q2 24
$1.0B
Q1 24
$1.0B
Net Profit
CRL
CRL
Q
Q
Q4 25
$-276.6M
Q3 25
$54.4M
$211.0M
Q2 25
$52.3M
Q1 25
$25.5M
Q4 24
$-214.5M
Q3 24
$69.7M
$199.0M
Q2 24
$94.1M
Q1 24
$73.0M
Gross Margin
CRL
CRL
Q
Q
Q4 25
Q3 25
45.1%
Q2 25
Q1 25
Q4 24
Q3 24
34.6%
47.0%
Q2 24
34.5%
Q1 24
34.1%
Operating Margin
CRL
CRL
Q
Q
Q4 25
-28.5%
Q3 25
13.3%
21.3%
Q2 25
9.7%
Q1 25
7.6%
Q4 24
-16.7%
Q3 24
11.6%
21.8%
Q2 24
14.8%
Q1 24
12.5%
Net Margin
CRL
CRL
Q
Q
Q4 25
-27.8%
Q3 25
5.4%
16.5%
Q2 25
5.1%
Q1 25
2.6%
Q4 24
-21.4%
Q3 24
6.9%
17.3%
Q2 24
9.2%
Q1 24
7.2%
EPS (diluted)
CRL
CRL
Q
Q
Q4 25
$-5.57
Q3 25
$1.10
$1.01
Q2 25
$1.06
Q1 25
$0.50
Q4 24
$-4.17
Q3 24
$1.33
$0.95
Q2 24
$1.74
Q1 24
$1.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRL
CRL
Q
Q
Cash + ST InvestmentsLiquidity on hand
$213.8M
$128.0M
Total DebtLower is stronger
$2.1B
$1.7B
Stockholders' EquityBook value
$3.2B
$9.1B
Total Assets
$7.1B
$12.5B
Debt / EquityLower = less leverage
0.68×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRL
CRL
Q
Q
Q4 25
$213.8M
Q3 25
$207.1M
$128.0M
Q2 25
$182.8M
Q1 25
$229.4M
Q4 24
$194.6M
Q3 24
$210.2M
Q2 24
$179.2M
Q1 24
$327.0M
Total Debt
CRL
CRL
Q
Q
Q4 25
$2.1B
Q3 25
$2.2B
$1.7B
Q2 25
$2.3B
Q1 25
$2.5B
Q4 24
$2.2B
Q3 24
$2.3B
Q2 24
$2.4B
Q1 24
$2.7B
Stockholders' Equity
CRL
CRL
Q
Q
Q4 25
$3.2B
Q3 25
$3.4B
$9.1B
Q2 25
$3.4B
Q1 25
$3.2B
Q4 24
$3.5B
Q3 24
$3.8B
$11.1B
Q2 24
$3.7B
Q1 24
$3.6B
Total Assets
CRL
CRL
Q
Q
Q4 25
$7.1B
Q3 25
$7.5B
$12.5B
Q2 25
$7.6B
Q1 25
$7.6B
Q4 24
$7.5B
Q3 24
$8.0B
Q2 24
$7.9B
Q1 24
$8.2B
Debt / Equity
CRL
CRL
Q
Q
Q4 25
0.68×
Q3 25
0.64×
0.19×
Q2 25
0.70×
Q1 25
0.79×
Q4 24
0.65×
Q3 24
0.62×
Q2 24
0.65×
Q1 24
0.73×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRL
CRL
Q
Q
Operating Cash FlowLast quarter
$147.5M
$782.0M
Free Cash FlowOCF − Capex
$58.6M
$568.0M
FCF MarginFCF / Revenue
5.9%
44.5%
Capex IntensityCapex / Revenue
8.9%
16.8%
Cash ConversionOCF / Net Profit
3.71×
TTM Free Cash FlowTrailing 4 quarters
$518.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRL
CRL
Q
Q
Q4 25
$147.5M
Q3 25
$213.8M
$782.0M
Q2 25
$204.6M
Q1 25
$171.7M
Q4 24
$159.4M
Q3 24
$251.8M
Q2 24
$193.5M
Q1 24
$129.9M
Free Cash Flow
CRL
CRL
Q
Q
Q4 25
$58.6M
Q3 25
$178.2M
$568.0M
Q2 25
$169.3M
Q1 25
$112.4M
Q4 24
$83.7M
Q3 24
$213.1M
Q2 24
$154.0M
Q1 24
$50.7M
FCF Margin
CRL
CRL
Q
Q
Q4 25
5.9%
Q3 25
17.7%
44.5%
Q2 25
16.4%
Q1 25
11.4%
Q4 24
8.4%
Q3 24
21.1%
Q2 24
15.0%
Q1 24
5.0%
Capex Intensity
CRL
CRL
Q
Q
Q4 25
8.9%
Q3 25
3.5%
16.8%
Q2 25
3.4%
Q1 25
6.0%
Q4 24
7.5%
Q3 24
3.8%
Q2 24
3.8%
Q1 24
7.8%
Cash Conversion
CRL
CRL
Q
Q
Q4 25
Q3 25
3.93×
3.71×
Q2 25
3.91×
Q1 25
6.74×
Q4 24
Q3 24
3.61×
Q2 24
2.06×
Q1 24
1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRL
CRL

Discovery And Safety Assessment Segment$591.6M60%
Manufacturing Support Segment$196.4M20%
Transferred At Point In Time$108.0M11%
Transferred Over Time$98.3M10%

Q
Q

Semiconductor Technologies$693.0M54%
Interconnect Solutions$583.0M46%

Related Comparisons